Resmed (RSMDF) EPS (Diluted) Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RSMDF) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 18.07% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 19.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.01% |
| Mar 31, 2026 | 20.15% |
| Dec 31, 2025 | 20.69% |
| Sep 30, 2025 | 18.37% |
| Jun 30, 2025 | 24.78% |
| Mar 31, 2025 | 26.74% |
| Dec 31, 2024 | 19.42% |
| Sep 30, 2024 | 15.02% |
| Jun 30, 2024 | 14.13% |
| Mar 31, 2024 | 79.45% |
| Dec 31, 2023 | 4.90% |
| Sep 30, 2023 | 6.81% |
| Jun 30, 2023 | 8.45% |
| Mar 31, 2023 | 12.10% |
| Dec 31, 2022 | 11.43% |
| Sep 30, 2022 | 19.99% |
| Jun 30, 2022 | 52.79% |
| Mar 31, 2022 | 18.59% |
| Dec 31, 2021 | 16.69% |
| Sep 30, 2021 | 23.61% |